| Identification | Back Directory | [Name]
2,4(1H,3H)-Pyrimidinedione,1-(3-azido-2,3-dideoxy-b-D-threo-pentofuranosyl)- | [CAS]
101039-96-7 | [Synonyms]
3’-β-Azido-2’,3’-dideoxyuridine
1-(3-Azido-2,3-dideoxy-b-D-threo-pentofuranosyl)-2,4(1H,3H)-pyrimidinedione
2,4(1H,3H)-Pyrimidinedione,1-(3-azido-2,3-dideoxy-b-D-threo-pentofuranosyl)-
1-(3-Azido-2,3-dideoxy-b-D-threo-pentofuranosyl)-2,4(1H,3H)-pyrimidinedione,3’-b-Azido-2’,3’-dideoxyuridine
3’-beta-Azido-2’,3’-dideoxyuridine, 1-(3-Azido-2,3-dideoxy-?-D-threo-pentofurano syl)-2,4 (1H,3H)-pyrimidinedione | [Molecular Formula]
C9H11N5O4 | [MDL Number]
MFCD00870324 | [MOL File]
101039-96-7.mol | [Molecular Weight]
253.22 |
| Hazard Information | Back Directory | [Uses]
3'-beta-Azido-2',3'-dideoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
T&W GROUP
|
| Tel: |
021-61551611 13296011611 |
| Website: |
www.trustwe.com/ |
|